These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
331 related articles for article (PubMed ID: 190633)
1. [The diagnostic value of the determination of cyclic 3',5'-adenosine monophosphate (cAMP) in urine]. Gennari C; Galli M; Montagnani M; D'Amore I Quad Sclavo Diagn; 1976 Mar; 12(1):15-38. PubMed ID: 190633 [TBL] [Abstract][Full Text] [Related]
2. Renal adenylate cyclase and the interrelationship between parathyroid hormone and vitamin D in the regulation of urinary phosphate and adenosine cyclic 3',5'-monophosphate excretion. Forte LR; Nickols GA; Anast CS J Clin Invest; 1976 Mar; 57(3):559-68. PubMed ID: 175088 [TBL] [Abstract][Full Text] [Related]
3. Mechanism of resistance to the phosphaturic effect of the parathyroid hormone in the hamster. Knox FG; Preiss J; Kim JK; Dousa TP J Clin Invest; 1977 Apr; 59(4):675-83. PubMed ID: 14974 [TBL] [Abstract][Full Text] [Related]
4. Effect of intravenous glucagon on the urinary excretion of adenosine 3',5'-monophosphate in man and in rats. Evidence for activation of renal adenylate cyclase and formation of nephrogenous cAMP. Rubinger D; Wald H; Friedlaender MM; Silver J; Popovtzer MM Miner Electrolyte Metab; 1988; 14(4):211-20. PubMed ID: 2850459 [TBL] [Abstract][Full Text] [Related]
5. The mechanism of urinary concentration in nephrogenic diabetes insipidus. McConnell RF; Lorentz WB; Berger M; Smith EH; Carvajal HF; Travis LB Pediatr Res; 1977 Jan; 11(1 Pt 1):33-6. PubMed ID: 188007 [TBL] [Abstract][Full Text] [Related]
6. Impaired production and decreased urinary excretion of adenosine 3',5'-monophosphate in primary hyperparathyroidism with vitamin D deficiency. Rubinger D; Friedlaender MM; Silver J; Wald H; Shumart T; Popovtzer MM Miner Electrolyte Metab; 1988; 14(5):283-7. PubMed ID: 2845240 [TBL] [Abstract][Full Text] [Related]
7. Effect of chlorpropamide on renal response to parathyroid hormone in normal subjects and in patients with hypoparathyroidism and pseudohypoparathyroidism. Coulson R; Moses AM J Pharmacol Exp Ther; 1975 Sep; 194(3):603-13. PubMed ID: 169346 [TBL] [Abstract][Full Text] [Related]
8. Source of urinary cyclic AMP in response to calcitonin and parathyroid hormone in the rat. Firek AF; Ramanathan S; Suh SM Res Commun Chem Pathol Pharmacol; 1990 Jan; 67(1):147-50. PubMed ID: 2158136 [TBL] [Abstract][Full Text] [Related]
9. Effects of parathyroid hormone on plasma and urinary adenosine 3',5'-monophosphate in man. Kaminsky NI; Broadus AE; Hardman JG; Jones DJ; Ball JH; Sutherland EW; Liddle GW J Clin Invest; 1970 Dec; 49(12):2387-95. PubMed ID: 5480862 [TBL] [Abstract][Full Text] [Related]
10. Effects of parathyroid hormone and calcitonin on stop-flow patterns of cyclic AMP, sodium, potassium, calcium and inorganic phosphate in thyroparathyroidectomized rabbits. Tabei K; Asano Y; Imai M Miner Electrolyte Metab; 1984; 10(1):36-42. PubMed ID: 6330514 [TBL] [Abstract][Full Text] [Related]
11. [Pseudohypoparathyroidism: investigations of the serum parathyroid hormone level, pte resistance and urinary camp excretion before and during vitamin d treatment (author's transl)]. Stögmann W Wien Klin Wochenschr Suppl; 1975; 33():1-15. PubMed ID: 176830 [TBL] [Abstract][Full Text] [Related]
12. The influence of parathyroid hormone and calcitonin on plasma levels of adenosine 3'5' monophosphate and electrolytes in normal and anephric subjects. Czekalski S; Baczyk K Proc Eur Dial Transplant Assoc; 1976; 12():272-80. PubMed ID: 180521 [TBL] [Abstract][Full Text] [Related]
13. Ionized calcium and cyclic AMP in plasma and urine. Biochemical evaluation in calcium metabolic disease. Thode J Scand J Clin Lab Invest Suppl; 1990; 197():1-45. PubMed ID: 2154030 [TBL] [Abstract][Full Text] [Related]
14. [Renal receptors of parathyroid hormone and calcitonin (author's transl)]. Ardaillou R Nouv Presse Med; 1978 Dec; 7(45):4125-30. PubMed ID: 218163 [TBL] [Abstract][Full Text] [Related]
15. [Urinary phosphate and cyclic adenosine monophosphate response to intravenous administration of synthetic human parathyroid hormone-(1-34) in idiopathic hypoparathyroidism, pseudohypoparathyroidism, pseudopseudohypoparathyroidism and normal subjects]. Fukami T; Fujita T; Yoshimoto Y; Fukase M; Imai Y; Sakaguchi K; Ogata E; Furukawa Y; Suzuki H; Takebe K Nihon Naibunpi Gakkai Zasshi; 1984 Mar; 60(3):159-70. PubMed ID: 6090236 [TBL] [Abstract][Full Text] [Related]